Metformina Ciclum

Metformin, the active ingredient in Metformina Ciclum, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus.

GNH USA supplies Metformina Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Ciclum is a biguanide antidiabetic that lowers blood glucose by acting on hepatic and peripheral pathways. - Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels. - Prediabetes (impaired fasting glucose): delays progression to overt diabetes. - Polycystic ovary syndrome (off‑label): helps restore regular ovulation and improve insulin sensitivity.

Metformina Ciclum may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, especially during treatment initiation. - Metallic taste: transient alteration of taste perception. - Abdominal discomfort: cramping or bloating. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: life‑threatening metabolic acidosis, requires immediate medical attention. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: abnormal liver function tests or hepatitis. - Vitamin B12 deficiency: may develop with long‑term use. - Hypoglycaemia: rare when combined with other glucose‑lowering agents.

Metformina Ciclum should be used with careful clinical monitoring to minimise risks. - Renal function assessment: avoid or adjust dose in patients with impaired kidney function. - Hepatic function monitoring: use cautiously in liver disease. - Blood glucose monitoring: regularly check glucose to avoid hypoglycaemia when combined with other agents. - Elderly patients: start with lower dose and titrate slowly. - Heart failure: contraindicated in severe, unstable heart failure. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Metformina Ciclum can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of renal impairment and lactic acidosis. - Alcohol: potentiates lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - NSAIDs: may impair renal function, increasing metformin exposure. - Calcium channel blockers: occasional reports of altered glucose control.